948895-95-2

Upstream product

• 530084-74-3 (R)-8-(benzyloxy)-5-(2-bromo-1-((tert-butyldimethylsilyl)oxy)ethyl)quinolin-2(1H)-one 
• 948895-93-0 1-{(2S)-1-[3-(2-phenylethoxy)propyl]pyrrolidin-2-yl}methanamine 
• 7531-52-4 L-prolinamide 
• 155526-40-2 3-phenethoxypropanoic acid 
• 93609-84-8 5-acetyl-8-benzyloxy-1H-quinolin-2-one 
• 100331-89-3 8-benzyloxy-5-(2-bromoacetyl)-1H-quinolin-2-one 
• 530084-79-8 8-(benzyloxy)-5-[(1R)-2-bromo-1-hydroxyethyl]quinolin-2(1H)-one 
• 69739-34-0 t-butyldimethylsiyl triflate 
• 948895-91-8 1-[3-(2-phenylethoxy)propanoyl]-L-prolinamide 

Downstream Products

• 948895-97-4 8-(benzyloxy)-5-{(1R)-1-hydroxy-2-[({(2S)-1-[3-(2-phenylethoxy)propyl]pyrrolidin-2-yl}methyl)amino]ethyl}quinolin-2(lh)-one 

Relevant academic research and scientific papers

PHENETHANOLAMINE DERIVATIVES AS BETA2 ADRENORECEPTOR AGONISTS

The present invention relates to compounds according to formula (I), a process for preparing them, the intermediate compounds of the process and the use of the compounds in the manufacture of a medicament for use in treating diseases such as ARDS, pulmonary emphysema, bronchitis, bronchiectasis, COPD, asthma and rhinitis. The compounds are beta2 adrenoreceptor agonists.